All In Biotech

Free tool

FAERS Monitor: Yondelis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207953 or its brand name (Yondelis, Trabectedin). Reports on generic versions are filed under their own applications.

Reports

2,350

Serious

2,142

91% of reports

Hospitalization

1,049

Death reported

464

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • neutropenia251
  • anaemia214
  • nausea206
  • thrombocytopenia202
  • febrile neutropenia163
  • pancytopenia161
  • off label use154
  • vomiting151
  • disease progression139
  • rhabdomyolysis132
  • alanine aminotransferase increased125
  • asthenia107
  • aspartate aminotransferase increased106
  • drug ineffective106
  • pyrexia103

Reports by year received

View as table
YearReports
20062
20077
20086
20094
201012
201144
201227
201328
201435
201582
2016344
2017254
2018266
2019213
2020151
2021132
2022157
2023153
2024173
2025127
2026133

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,809 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rhabdomyolysisSignal13228.424.13,461
pancytopeniaSignal16125.922.33,821
febrile neutropeniaSignal16322.019.03,256
alanine aminotransferase increasedSignal12518.315.42,024
aspartate aminotransferase increasedSignal10617.914.91,675
neutropeniaSignal25116.614.73,669
thrombocytopeniaSignal20216.214.22,875
disease progressionSignal13910.59.01,194
anaemiaSignal21410.18.81,749
vomitingSignal1512.92.5187
pyrexiaSignal1032.72.2107
astheniaSignal1072.52.1101
nauseaSignal2062.32.0161
off label use1541.61.433
drug ineffective1060.70.612

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.